Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.
Study reference: NCT06856161. HopeStage can help you review the study, but cannot decide medical eligibility.
RecruitingNCT06856161
A Novel Blood Test as a Biomarker in Mental Health
This study is recruiting. It focuses on depression and currently lists participation information in Canada.
DepressionOtherOver 19 Years
Key information made simple
This observational study is following people with depression, anxiety, or psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information. This study may not offer a new treatment, and its main value is helping researchers learn from follow-up information that may improve future care.
Your next step
The official record suggests in-person participation through a hospital, with sites including Royal Columbian Hospital in New Westminster. Participation appears to center on assessments, scans, or samples rather than trying a new treatment. The main fit is usually being able to follow the planned visits or tasks and meeting the main study requirements, while common reasons not to take part include active substance or alcohol problems that could affect the results and other factors that could make participation unsuitable. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Sponsor
- Fraser Health
- Sponsor type
- Unknown or unclear
- Main activity
- observational follow-up
- Intervention
- Not available
- Time commitment
- long follow-up or multiple visits
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Recruiting
- Source
- Official registry link
Key study information
- Official title
- A Novel Blood Test as a Biomarker in Mental Health
- Condition
- Depression - Major Depressive Disorder; Schizophenia Disorder; Psychosis; Mania (Neurotic); Alcohol Consumption; Anxiety Disorder (Panic Disorder or GAD); Substance Use Disorders; Alcohol Use Disorder
- Study status
- Recruiting
- Sponsor / lead affiliation
- Fraser Health
- Location / country
- Canada
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT06856161
Why this study may matter
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help clarify how this condition is measured or understood.
It requires regular follow-up, often through questionnaires or interviews.
Requires travel, with in-person participation in Canada.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Official title
- A Novel Blood Test as a Biomarker in Mental Health
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT06856161
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is A Novel Blood Test as a Biomarker in Mental Health?
This study is exploring observational follow-up for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by Fraser Health. We could not clearly classify the sponsor type from the available data. Check the official source record to verify who is responsible for the study.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve observational follow-up, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me